Immunogenetics: changing the face of immunodeficiency

Area of Science:

• Immunology
• Genetics
• Molecular Biology

Background:

• Significant progress has been made in identifying molecular defects underlying primary immunodeficiencies over the last decade.
• The identification of the SAP gene defect in X-linked lymphoproliferative disease (XLP) completes the molecular basis for all recognized X-linked syndromes.

Purpose of the Study:

• To review the advances in molecular diagnostics for primary immunodeficiencies.
• To highlight the clinical benefits of molecular diagnosis, including earlier treatment options.
• To emphasize the role of gene defect identification in understanding disease pathogenesis.

Main Methods:

• Review of recent literature and genetic studies on primary immunodeficiencies.
• Analysis of molecular diagnostic techniques and their clinical applications.
• Examination of the functional studies on specific genes (e.g., WASP, gamma c/JAK-3 pathway).

Main Results:

• Molecular defects for most primary immunodeficiencies are now defined.
• The identification of SAP completes the molecular basis for X-linked syndromes.
• Genes for DiGeorge syndrome, hyper-IgE, and common variable immunodeficiency remain to be identified.

Conclusions:

• Molecular diagnosis enables more accurate and rapid identification of primary immunodeficiencies.
• Molecular diagnosis facilitates earlier and more definitive treatments, including bone marrow transplantation and gene therapy.
• Identifying gene defects is fundamental to understanding the molecular pathogenesis of immunological abnormalities.